Effects of the chromanol HMR 1556 on potassium currents in atrial myocytes

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 367, Issue 3, 2003, Pages 281-288

  Bosch, Ralph F ^a   Schneck, Alexander C ^a   Csillag, Saskia ^a   Eigenberger, Bernd ^a   Gerlach, Uwe ^b   Brendel, Joachim ^b   Lang, Hans J ^b   Mewis, Christian ^a   Gögelein, Heinz ^b   Seipel, Ludger ^a   Kühlkamp, Volker ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Antiarrhythmic agents; Arrhythmia; Guinea pig; Human; Ion channels; K+ channel; Membrane currents

Indexed keywords

ANTIARRHYTHMIC AGENT; N [3 HYDROXY 2,2 DIMETHYL 6 (4,4,4 TRIFLUOROBUTOXY)CHROMAN 4 YL] N METHYLMETHANESULFONAMIDE; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG SELECTIVITY; FEMALE; GUINEA PIG; HEART ATRIUM; HEART REPOLARIZATION; HUMAN; HUMAN CELL; MALE; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; STEADY STATE; XENOPUS;

AGED; ANIMALS; CELLS, CULTURED; CHROMANS; DELAYED RECTIFIER POTASSIUM CHANNELS; FEMALE; GUINEA PIGS; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; POTASSIUM CHANNELS, VOLTAGE-GATED; SULFONAMIDES;

EID: 12444290928     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-002-0672-5     Document Type: Article

References (43)

1. Barry DM, Trimmer JS, Merlie JP, Nerbonne JM (1995) Differential expression of voltage-gated K+ channel subunits in adult rat heart. Relation to functional K+ channels? Circ Res 77:361-369
2. Ks-blocking agent chromanol 293B on individual muscle layers of the intact canine heart. Circulation 100:2184-2190
3. + current, on repolarization in human and guinea pig ventricular myocytes. Cardiovasc Res 38:441-450
4. Bosch RF, Milek IV, Popovic K, Mermi J, Mewis C, Kühlkamp V, Seipel L (1999a) Ambasilide prolongs the action potential and blocks multiple potassium currents in human atrium. J Cardiovasc Pharmacol 33:762-771
5. Bosch RF, Wang Z, Li GR, Nattel S (1999b) Electrophysiological mechanisms by which hypothyroidism delays repolarization in guinea pig hearts. Am J Physiol 277:H211-H220
6. sK channels by the chromanol 293B. Pflugers Arch 432:1094-1096
7. Crumb WJ, Pigott JD, Clarkson CW (1995) Description of a non-selective cation current in human atrium. Circ Res 77:950-956
8. + channel current. Circ Res 73:210-216
9. Feng J, Wible B, Li GR, Wang Z, Nattel S (1997) Antisense oligodeoxynucleotides directed against Kv1.5 mRNA specifically inhibit ultrarapid delayed rectifier K+ current in cultured adult human atrial myocytes. Circ Res 80:572-579
10. + channel protein in mammalian cells and immunolocalization in guinea pig heart. Circ Res 73:968-973
11. Gerlach U, Brendel J, Bruggemann A (2001) Synthesis and SAR of novel IKs channel blockers: from K(ATP) channel opener to IKs channel blocker. J Med Chem 44:3831-3837
12. Gintant GA (1996) Two components of delayed rectifier current in canine atrium and ventricle. Does IKs play a role in reverse rate dependence of class III agents? Circ Res 78:26-37
13. Gögelein H, Bruggemann A, Gerlach U, Brendel J, Busch AE (2000) Inhibition of I-Ks channels by HMR 1556. Naunyn-Schmiedebergs Arch Pharmacol 362:480-488
14. Hondeghem LM, Snyders DJ (1990) Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence. Circulation 81:686-690
15. + current by dofetilide. Circ Res 72:75-83
16. + current in human ventricular myocytes. Circ Res 78:689-696
17. Lynch JJ, Baskin EP, Nutt EM, Guinosso PJ, Hamill T, Salata JJ, Woods CM (1995) Comparison of binding to rapidly activating delayed rectifier K+ channel, IKr, and effects on myocardial refractoriness for class III antiarrhythmic agents. J Cardiovasc Pharmacol 25:336-340
18. Ks, in canine models of malignant ischemic ventricular arrhythmia. Circulation 100:1917-1923
19. Majumder K, De Biasi M, Wang Z, Wible BA (1995) Molecular cloning and functional expression of a novel potassium channel beta-subunit from human atrium. FEBS Lett 361:13-16
20. Nattel S (1999) The molecular and ionic specificity of antiarrhythmic drug actions. J Cardiovasc Electrophysiol 10:272-282
21. Nattel S, Liu L, St Georges D (1998) Effects of the novel antiarrhythmic agent azimilide on experimental atrial fibrillation and atrial electrophysiologic properties. Cardiovasc Res 37:627-635
22. Nattel S, Yue L, Wang Z (1999) Cardiac ultrarapid delayed rectifiers: a novel potassium current family of functional similarity and molecular diversity. Cell Physiol Biochem 9:217-226
23. Page RL, Connolly SJ, Wilkinson WE, Marcello SR, Schnell DJ, Pritchett EL (2002) Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose-response. Am Heart J 143:643-649
24. Pritchett EL, Page RL, Connolly SJ, Marcello SR, Schnell DJ, Wilkinson WE (2000) Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators. J Am Coll Cardiol 36:794-802
25. Roden DM (1993) Current status of class III antiarrhythmic drug therapy. Am J Cardiol 72:44B-49B
26. + current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 96:195-215
27. + current is composed of two currents in guinea pig atrial cells. Am J Physiol 260:H393-H399
28. Singh BN, Vaughan Williams EM (1970) A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474. Br J Pharmacol 39:675-687
29. Singh S, Zoble RG, Yellen L, Brodsky MA, Feld GK, Berk M, Billing CB (2000) Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter - The Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study. Circulation 102:2385-2390
30. Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT (1997) Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet 17:338-340
31. Stambler BS, Wood MA, Ellenbogen KA (1996a) Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing. Am J Cardiol 77:960-966
32. Stambler BS, Wood MA, Ellenbogen KA, Perry KT, Wakefield LK, VanderLugt JT (1996b) Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. Circulation 94:1613-1621
33. Torp PC, Moller M, Bloch TP, Kober L, Sandoe E, Egstrup K, Agner E, Carlsen J, Videbaek J, Marchant B, Camm AJ (1999) Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med 341:857-865
34. Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP (1996) Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival with oral d-sotalol. Lancet 348:7-12; erratum 348:416
35. Wang J, Bourne GW, Wang Z, Villemaire C, Talajic M (1993a) Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation: importance of use-dependent effects on refractoriness. Circulation 88:1030-1044
36. Wang J, Feng J, Nattel S (1994a) Class III antiarrhythmic drug action in experimental atrial fibrillation. Differences in reverse use dependence and effectiveness between d-sotalol and the new antiarrhythmic drug ambasilide. Circulation 90:2032-2040
37. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, Van Raay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, Schwartz PJ, Towbin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, Keating MT (1996a) Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 12:17-23
38. Wang Z, Fermini B, Nattel S (1993b) Delayed rectifier outward current and repolarization in human atrial myocytes. Circ Res 73:276-285
39. + current similar to Kv1.5 cloned channel currents. Circ Res 73:1061-1076
40. Wang Z, Fermini B, Nattel S (1994b) Rapid and slow components of delayed rectifier current in human atrial myocytes. Cardiovasc Res 28:1540-1546
41. Wang Z, Kiehn J, Yang Q, Brown AM, Wible BA (1996b) Comparison of binding and block produced by alternatively spliced Kvbeta1 subunits. J Biol Chem 271:28311-28317
42. Kr) in AT-1 cells. Circulation 91:1799-1806
43. Yue L, Feng J, Li GR, Nattel S (1996) Transient outward and delayed rectifier currents in canine atrium. Properties and role of isolation methods. Am J Physiol 270:H2157-H2168